Works matching Hyperthermic intraperitoneal chemotherapy


Results: 2319
    1
    2
    3
    4
    5
    6
    7
    8

    PROPHYLACTIC HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) FOR THE PREVENTION AND CONTROL OF PERITONEAL METASTASIS IN PATIENTS WITH GASTROINTESTINAL MALIGNANCIES: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS .

    Published in:
    EXCLI Journal, 2021, v. 20, p. 1328, doi. 10.17179/excli2021-4108
    By:
    • Dominic, Jerry Lorren;
    • Kannan, Amudhan;
    • Tara, Anjli;
    • Hakim Mohammed, Abdul Rub;
    • Win, Myat;
    • Khorochkov, Arseni;
    • Sultan, Waleed;
    • Ahmed, Asma;
    • Kantamaneni, Ketan;
    • Syzmanski, Michael W.;
    • Singh, Rajbir;
    • Marquez, Raul A.;
    • Asarian, Armand;
    • Thirunavukarasu, Pragatheeshwar;
    • Keckeisen, George
    Publication type:
    Article
    9
    10

    Hyperthermic intraperitoneal chemotherapy (HIPEC) in combined treatment of locally advanced and intraperitonealy disseminated gastric cancer: A retrospective cooperative Central‐Eastern European study.

    Published in:
    Cancer Medicine, 2019, v. 8, n. 6, p. 2877, doi. 10.1002/cam4.2204
    By:
    • Yarema, Roman;
    • Mielko, Jerzy;
    • Fetsych, Taras;
    • Ohorchak, Myron;
    • Skorzewska, Magdalena;
    • Rawicz‐Pruszyński, Karol;
    • Mashukov, Artem;
    • Maksimovsky, Viatcheslav;
    • Jastrzębski, Tomasz;
    • Polkowski, Wojciech;
    • Gyrya, Petro;
    • Kovalchuk, Yuriy;
    • Safiyan, Victor;
    • Karelin, Ivan;
    • Kopetskiy, Viatcheslav;
    • Kolesnik, Olena;
    • Kondratskiy, Yuriy;
    • Paskonis, Marius
    Publication type:
    Article
    11
    12

    Hyperthermic intrathoracic/intraperitoneal chemotherapy versus conventional intrapleural/intraperitoneal chemotherapy for the malignant effusion: a multi-center randomized clinical trial.

    Published in:
    International Journal of Hyperthermia, 2023, v. 40, n. 1, p. 1, doi. 10.1080/02656736.2023.2241689
    By:
    • Liu, Lili;
    • Zhang, Tao;
    • Song, Xiang;
    • Liao, Cheng-gong;
    • Xu, Tengyun;
    • Yang, Yang;
    • Zeng, Ming;
    • Jia, Junmei;
    • Su, Haichuan;
    • Song, Yang;
    • Min, Jie;
    • Zhang, Hongmei;
    • Li, Wei;
    • Zhang, Hongwei;
    • Zhang, Helong
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20

    Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial.

    Published in:
    BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1430-7
    By:
    • Klaver, Charlotte E. L.;
    • Musters, Gijsbert D.;
    • Bemelman, Willem A.;
    • Punt, Cornelis J. A.;
    • Verwaal, Victor J.;
    • Dijkgraaf, Marcel G. W.;
    • Aalbers, Arend G. J.;
    • van der Bilt, Jarmila D. W.;
    • Boerma, Djamila;
    • Bremers, Andre J. A.;
    • Burger, Jacobus W. A.;
    • Buskens, Christianne J.;
    • Evers, Pauline;
    • van Ginkel, Robert J.;
    • van Grevenstein, Wilhelmina M. U.;
    • Hemmer, Patrick H. J.;
    • de Hingh, Ignace H. J. T.;
    • Lammers, Laureen A.;
    • van Leeuwen, Barbara L.;
    • Meijerink, Wilhelmus J. H. J.
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery for gastric carcinoma at high risk of peritoneal carcinomatosis: short and long-term outcomes (GOETH STUDY)-a collaborative randomized controlled trial by ACOI, FONDAZIONE AIOM, SIC, SICE, and SICO.

    Published in:
    2022
    By:
    • Di Giorgio, A.;
    • Gerardi, C.;
    • Abatini, C.;
    • Melotti, G.;
    • Bonavina, L.;
    • Torri, V.;
    • Santullo, F.;
    • Garattini, S.;
    • De Luca, M.;
    • Rulli, Erica;
    • Rulli, Eliana;
    • Pacelli, F.;
    • GOETH Investigators
    Publication type:
    journal article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Elevated temperatures and longer durations improve the efficacy of oxaliplatin- and mitomycin C-based hyperthermic intraperitoneal chemotherapy in a confirmed rat model for peritoneal metastasis of colorectal cancer origin.

    Published in:
    Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1122755
    By:
    • Helderman, Roxan F. C. P. A.;
    • Bokan, Bella;
    • van Bochove, Gregor G. W.;
    • Rodermond, Hans M.;
    • Thijssen, Elsy;
    • Marchal, Wouter;
    • Torang, Arezo;
    • Löke, Daan R.;
    • Franken, Nicolaas A. P.;
    • Petra Kok, H.;
    • Tanis, Pieter J.;
    • Crezee, Johannes;
    • Oei, Arlene L.
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49